PFM Health Sciences’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Hold |
0
| – | – | – | 73 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 80 |
|
|
2021
Q1 | – | Sell |
-451,275
| Closed | -$28M | – | 81 |
|
|
2020
Q4 | $28M | Buy |
+451,275
| New | +$28M | 0.98% | 34 |
|
|
2018
Q2 | – | Sell |
-3,123,145
| Closed | -$198M | – | 107 |
|
|
2018
Q1 | $198M | Buy |
+3,123,145
| New | +$198M | 4.01% | 1 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 91 |
|
|
2016
Q3 | – | Sell |
-519,722
| Closed | -$38.2M | – | 83 |
|
|
2016
Q2 | $38.2M | Sell |
519,722
-1,330,649
| -72% | -$97.9M | 1.15% | 35 |
|
|
2016
Q1 | $118M | Sell |
1,850,371
-1,003,469
| -35% | -$64.1M | 3.65% | 4 |
|
|
2015
Q4 | $196M | Buy |
2,853,840
+778,063
| +37% | +$53.5M | 5.97% | 1 |
|
|
2015
Q3 | $123M | Sell |
2,075,777
-28,191
| -1% | -$1.67M | 3.46% | 7 |
|
|
2015
Q2 | $140M | Buy |
2,103,968
+1,308,622
| +165% | +$87.1M | 3.54% | 5 |
|
|
2015
Q1 | $51.3M | Buy |
+795,346
| New | +$51.3M | 1.41% | 30 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 89 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 65 |
|
|
2014
Q2 | – | Sell |
-7,722,083
| Closed | -$401M | – | 65 |
|
|
2014
Q1 | $401M | Buy |
7,722,083
+190,076
| +3% | +$9.87M | 7.27% | 2 |
|
|
2013
Q4 | $400M | Buy |
+7,532,007
| New | +$400M | 8.05% | 1 |
|